Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Agnes Bonifacius

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 14, 2025
Transfer of Herpes Simplex Virus Type 1 (HSV-1) Specific T Cells in a Pediatric Patient Post-HSCT With Severe, Acyclovir-resistant HSV-1 InfectionAstrid Wintering, Agnes Bonifacius, Sabine Tischer-Zimmermann, et al.
European Journal of Immunology|November 6, 2025
Epigenetically Controlled ZEB2 Expression Promotes the Cytotoxic Potential of CMV-Specific CD8<sup>+</sup> T CellsVarun Sasidharan Nair, Zheng Yu, Hosein Ahmadi, et al.
Frontiers in Immunology|August 28, 2020
<i>Staphylococcus aureus</i> Alpha-Toxin Limits Type 1 While Fostering Type 3 Immune ResponsesAgnes Bonifacius, Oliver Goldmann, Stefan Floess, et al.
The Journal of Infection|November 1, 2023
Memory B cells anticipate SARS-CoV-2 variants through somatic hypermutationMatthias Bruhn, Maureen Obara, Abhishek Chiyyeadu, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 29, 2023
Adoptive Allogeneic T-Cell Therapy Improves the Clinical Outcome of JC Virus Granule Cell Neuronopathy: A Case ReportLea Grote-Levi, Nora Möhn, Agnes Bonifacius, et al.
European Radiology|March 9, 2024
Alveolar membrane and capillary function in COVID-19 convalescents: insights from chest MRIAgilo Luitger Kern, Isabell Pink, Agnes Bonifacius, et al.
Journal of Clinical Immunology|January 6, 2022
Antiviral T-Cell Frequencies in a Healthy Population: Reference Values for Evaluating Antiviral Immune Cell Profiles in Immunocompromised PatientsFriederike C Schulze Lammers, Agnes Bonifacius, Sabine Tischer-Zimmermann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2023
Chronic Active Epstein-Barr Virus (EBV) Infection Controlled by Allogeneic Stem Cell Transplantation and EBV-Specific T CellsElisabeth Meedt, Daniela Weber, Agnes Bonifacius, et al.
Therapeutic Advances in Neurological Disorders|May 30, 2024
Combined treatment with allogeneic Epstein-Barr- and human polyomavirus 1 specific T-cells in progressive multifocal leukoencephalopathy and EBV infection: a case reportSandra Nay, Nora Möhn, Lea Grote-Levi, et al.
Plos One|November 2, 2022
Reduced humoral but stable cellular SARS-CoV-2-specific immunity in liver transplant recipients in the first year after COVID-19Theresa Kirchner, Sophia Heinrich, Agnes Bonifacius, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 14, 2025
Transfer of Herpes Simplex Virus Type 1 (HSV-1) Specific T Cells in a Pediatric Patient Post-HSCT With Severe, Acyclovir-resistant HSV-1 InfectionAstrid Wintering, Agnes Bonifacius, Sabine Tischer-Zimmermann, et al.
European Journal of Immunology|November 6, 2025
Epigenetically Controlled ZEB2 Expression Promotes the Cytotoxic Potential of CMV-Specific CD8<sup>+</sup> T CellsVarun Sasidharan Nair, Zheng Yu, Hosein Ahmadi, et al.
Frontiers in Immunology|August 28, 2020
<i>Staphylococcus aureus</i> Alpha-Toxin Limits Type 1 While Fostering Type 3 Immune ResponsesAgnes Bonifacius, Oliver Goldmann, Stefan Floess, et al.
The Journal of Infection|November 1, 2023
Memory B cells anticipate SARS-CoV-2 variants through somatic hypermutationMatthias Bruhn, Maureen Obara, Abhishek Chiyyeadu, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 29, 2023
Adoptive Allogeneic T-Cell Therapy Improves the Clinical Outcome of JC Virus Granule Cell Neuronopathy: A Case ReportLea Grote-Levi, Nora Möhn, Agnes Bonifacius, et al.
European Radiology|March 9, 2024
Alveolar membrane and capillary function in COVID-19 convalescents: insights from chest MRIAgilo Luitger Kern, Isabell Pink, Agnes Bonifacius, et al.
Journal of Clinical Immunology|January 6, 2022
Antiviral T-Cell Frequencies in a Healthy Population: Reference Values for Evaluating Antiviral Immune Cell Profiles in Immunocompromised PatientsFriederike C Schulze Lammers, Agnes Bonifacius, Sabine Tischer-Zimmermann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2023
Chronic Active Epstein-Barr Virus (EBV) Infection Controlled by Allogeneic Stem Cell Transplantation and EBV-Specific T CellsElisabeth Meedt, Daniela Weber, Agnes Bonifacius, et al.
Therapeutic Advances in Neurological Disorders|May 30, 2024
Combined treatment with allogeneic Epstein-Barr- and human polyomavirus 1 specific T-cells in progressive multifocal leukoencephalopathy and EBV infection: a case reportSandra Nay, Nora Möhn, Lea Grote-Levi, et al.
Plos One|November 2, 2022
Reduced humoral but stable cellular SARS-CoV-2-specific immunity in liver transplant recipients in the first year after COVID-19Theresa Kirchner, Sophia Heinrich, Agnes Bonifacius, et al.
Pageof 4